Women want a low-dose birth control option
In an online survey of 1000 women considering hormonal birth control1
The survey conducted by Bayer in September 2019 included women aged 18-44 who were currently taking or considering taking hormonal prescription birth control in the next 12 months.1
Kyleena acts locally and provides low hormone levels
Comparison of simulated typical serum LNG concentrations2*
Low daily release rates3
High contraceptive efficacy maintained over 5 years3
Kyleena is the lowest-dose 5-year IUD3
The efficacy of Kyleena over 5 years was studied in parous and nulliparous women across a broad range of ages and body mass index (BMI).3
- Ages in the clinical trial subjects ranged from 18 to 35
- The weight range for Kyleena-treated women was 38 kg to 173 kg (84 lbs to 381 lbs)
- Mean BMI was 25.3 kg/m2 (range 15.2-57.6 kg/m2)
Year 1: Pearl Index of 0.16; 95% upper CL of 0.58; cumulative 5-year pregnancy rate, based on 13 pregnancies, estimated by the Kaplan-Meier method was 1.45%; 95% upper CL of 2.53%.3
Request a Rep
Stay up to date with clinical information and virtual trainings for Kyleena.
See how Kyleena impacts bleeding
Know what patients may expect in the first 3 to 6 months and up to 5 years of use.
A non-daily contraception option
Learn more about Kyleena as a non-daily contraception option.